Riskpilot← Back to searchSign inGet full accessArthoculus Oy
OYDissolvedY-tunnus 3187295-2Munkkiniemen Puistotie 5-A14Medical specialists activities · NACE 8622Est. 2021— employees
Revenue 2025
EUR 531K
+10% vs 2024
EBITDA margin
66.8%
+26% vs 2024
Equity ratio
96.0%
Financial strength
Net profit 2025
EUR 283K
+25% vs 2024
| Revenue | EUR 531K | +10% |
| EBITDA | EUR 354K | +26% |
| Net profit | EUR 283K | +25% |
| Total assets | EUR 752K | +49% |
| Equity | EUR 723K | +51% |
| Employees | — | — |
Legal name
Arthoculus Oy
Y-tunnus number
3187295-2
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
30. tammikuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Erikoislääkäripalvelut
Address
Munkkiniemen Puistotie 5-A14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 47 | 186 | 357 | 481 | 531 |
| Staff expenses | — | −13 | −29 | −81 | −58 |
| EBITDA | 29 | 98 | 228 | 281 | 354 |
| Depreciation & amort. | — | −0 | −0 | −1 | −1 |
| EBIT | 29 | 97 | 228 | 279 | 353 |
| Net financials | −0 | 0 | 0 | 4 | 1 |
| Profit before tax | 29 | 98 | 228 | 283 | 354 |
| Tax | 6 | 20 | 46 | 57 | 71 |
| Net profit | 24 | 77 | 182 | 226 | 283 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 27 | 102 | 298 | 506 | 752 |
| Equity | 24 | 99 | 273 | 477 | 723 |
| Long-term debt | — | — | 0 | 1 | 1 |
| Short-term debt | 3 | 3 | 25 | 28 | 29 |
| Total debt | 3 | 3 | 25 | 29 | 30 |
EBITDA margin
66.8%
This company
15.8%
Market median
+323% vs market
20212025
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
20212025
Return on equity
39.2%
This company
18.4%
Market median
+113% vs market
20212025
Net profit margin
53.4%
This company
8.1%
Market median
+559% vs market
20212025
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TM Audit | Audit | 2023 |
TD Chief Executive Officer | Chief Executive Officer | 2021 |
AH Deputy Member | Deputy Member | 2026 |
MS Deputy auditor | Deputy auditor | 2023 |
| Former (1) | ||
DK Deputy Member | Deputy Member | 2021 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Arthoculus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Matti Kervinen | Audit | 0 companies |
| Thomas Dietrich Ilmari Schlenzka | Chief Executive Officer | 0 companies |
| Dietrich Kurt Adolf Schlenzka | Deputy Member | 0 companies |
| Annariitta Helena Elisabeth Aronen | Deputy Member | 0 companies |
| Martta Siiri Maria Hakala | Deputy auditor | 0 companies |
| Anna Maria Kristiina Schlenzka | Chairperson | 0 companies |